Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health
PHASE1
This is a partially randomized, open-label phase 1 study to evaluate the sa...
Status
Recruiting
Location
Bridge HIV, San Francisco Department of Public Health
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Volunteers
PHASE1
This is a randomized, active-controlled, dose-escalation multi-center study...
A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects.
PHASE1
Phase 1 study to evaluate two doses of Alum Adjuvanted Zika Virus Purified ...
Status
Completed
Location
Walter Reed Army Institute of Research - Clinical Trials Center
Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults
PHASE1
Background:
Respiratory Syncytial Virus (RSV) is a virus that infects the ...